Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

T. Karampelas · SciRah

Researcher profile · Semantic Scholar

T. Karampelas

Share profile

T. Karampelas — researcher profile on SciRah

h-index: 11
Works: 29
Citations: 451

Most-cited papers

Chemoembolization of Hepatocellular Carcinoma with Hepasphere 30–60 μm. Safety and Efficacy Study
K. Malagari, M. Pomoni, H. Moschouris, A. Kelekis +12 more
2013Cardiovascular and Interventional Radiology110 citations Open access
Semantic Scholar
Nurr1:RXRα heterodimer activation as monotherapy for Parkinson’s disease
Athanasios D Spathis, Xenophon Asvos, Despina Ziavra, T. Karampelas +11 more
2017Proceedings of the National Academy of Sciences of the United States of America72 citations Open access
Semantic Scholar
GnRH-Gemcitabine conjugates for the treatment of androgen-independent prostate cancer: pharmacokinetic enhancements combined with targeted drug delivery.
T. Karampelas, O. Argyros, Nisar Sayyad, K. Spyridaki +8 more
2014Bioconjugate chemistry48 citations Open access
Semantic Scholar
Development of programmable gemcitabine-GnRH pro-drugs bearing linker controllable "click" oxime bond tethers and preclinical evaluation against prostate cancer.
Eirinaios I Vrettos, T. Karampelas, Nisar Sayyad, A. Kougioumtzi +5 more
2020European journal of medicinal chemistry32 citations Open access
Semantic Scholar
Pharmacokinetics, Safety, and Efficacy of Chemoembolization with Doxorubicin-Loaded Tightly Calibrated Small Microspheres in Patients with Hepatocellular Carcinoma
K. Malagari, T. Kiakidis, M. Pomoni, H. Moschouris +16 more
2016Cardiovascular and Interventional Radiology30 citations
Semantic Scholar
Development of bioactive gemcitabine-D-Lys6-GnRH prodrugs with linker-controllable drug release rate and enhanced biopharmaceutical profile.
Nisar Sayyad, Eirinaios I Vrettos, T. Karampelas, C. Chatzigiannis +4 more
2019European journal of medicinal chemistry25 citations Open access
Semantic Scholar
Peptide-Drug Conjugate GnRH-Sunitinib Targets Angiogenesis Selectively at the Site of Action to Inhibit Tumor Growth.
O. Argyros, T. Karampelas, Xenophon Asvos, A. Varela +6 more
2016Cancer Research25 citations Open access
Semantic Scholar
Gemcitabine Based Peptide Conjugate with Improved Metabolic Properties and Dual Mode of Efficacy.
T. Karampelas, E. Skavatsou, O. Argyros, Demosthenes Fokas +1 more
2017Molecular Pharmaceutics22 citations
Semantic Scholar
Design, synthesis and biological evaluation of novel substituted purine isosters as EGFR kinase inhibitors, with promising pharmacokinetic profile and in vivo efficacy.
Efthymios-Spyridon Gavriil, Aris Doukatas, T. Karampelas, V. Myrianthopoulos +5 more
2019European journal of medicinal chemistry21 citations
Semantic Scholar
Integrin-Mediated Targeted Cancer Therapy Using c(RGDyK)-Based Conjugates of Gemcitabine.
Theodora Chatzisideri, G. Leonidis, T. Karampelas, E. Skavatsou +4 more
2021Journal of Medicinal Chemistry15 citations Open access
Semantic Scholar
Immunotherapy Combined with Metronomic Dosing: An Effective Approach for the Treatment of NSCLC
E. Skavatsou, M. Semitekolou, I. Morianos, T. Karampelas +3 more
2021Cancers14 citations Open access
Semantic Scholar
Versatile quarto stimuli nanostructure based on Trojan Horse approach for cancer therapy: Synthesis, characterization, in vitro and in vivo studies.
E. Efthimiadou, E. Fragogeorgi, Lazaros Palamaris, T. Karampelas +5 more
2017Materials Science and Engineering C: Materials for Biological Applications11 citations
Semantic Scholar
Targeting of the breast cancer microenvironment with a potent and linkable oxindole based antiangiogenic small molecule
O. Argyros, T. Karampelas, A. Varela, Xenophon Asvos +6 more
2017OncoTarget9 citations Open access
Semantic Scholar
Developing MYC Degraders Bearing the Von Hippel–Lindau Ligand to Target the “Undruggable” MYC
Christos Siokatas, Alexandra Lampropoulou, Alexandra Smina, Katerina Soupsana +7 more
2024ACS Pharmacology & Translational Science8 citations Open access
Semantic Scholar
Enhancement of Docetaxel Absorption Using Ritonavir in an Oral Milk-Based Formulation
K. Soulele, T. Karampelas, C. Tamvakopoulos, P. Macheras
2021Pharmaceutical Research4 citations
Semantic Scholar
BRF110, an Orally Active Nurr1-RXRα-Selective Rexinoid, Enhances BDNF Expression without Elevating Triglycerides
Xenophon Asvos, M. A. El Mubarak, T. Karampelas, T. Rampias +6 more
2025Journal of Medicinal Chemistry3 citations Open access
Semantic Scholar
A fluorescent gemcitabine prodrug that follows a nucleoside transporter-independent internalization and bears enhanced therapeutic efficacy with respect to gemcitabine.
Eirinaios I Vrettos, Stavroula G. Kyrkou, Vasiliki Zoi, M. Giannakopoulou +14 more
2024Chemistry2 citations Open access
Semantic Scholar
Combination of Doxorubicin and Antiangiogenic Agents in Drug-Eluting Beads: In Vitro Loading and Release Dynamics in View of a Novel Therapeutic Approach for Hepatocellular Carcinoma
M. Krokidis, Danae Fakitsa, Katerina Malagari, T. Karampelas +3 more
2024Cardiovascular and Interventional Radiology1 citations
Semantic Scholar
RADIOCHEMISTRY AND PRECLINICAL IMAGING WORKFLOW FOR TRACKING 225AC DAUGHTER EMISSIONS IN A FAP-TARGETED ONCOLOGY MODEL
Eliza Lambidis, E. Fysikopoulos, T. Karampelas, M. Rouchota +2 more
2026EANM Innovation0 citations Open access
Semantic Scholar
Exploring Tumor Targeting with Various Radionuclides: A Comparative Evaluation of Theranostic Radionuclides, SPECT-Compliant Radionuclides and Alpha-Emitters
Sofia M Lagoumtzi, Eliza Lambidis, Sophia Sarpaki, T. Karampelas +1 more
2025Nuclear Medicine and Biology0 citations
Semantic Scholar
A preclinical platform for the radiolabelling and in vivo monitoring of nanoparticles against Crohn’s Disease using live dynamic SPECT imaging
T. Karampelas, M. Rouchota, S. Sarpaki, Antonis Skliris +5 more
2022Nuclear Medicine and Biology0 citations
Semantic Scholar
Abstract LB-271: Antitumor activity of new epidermal growth factor receptor inhibitors in non-small cell lung and breast cancer
Aris Doukatas, Efthymios-Spyridon Gavriil, T. Karampelas, P. Marakos +2 more
2018Experimental and Molecular Therapeutics0 citations
Semantic Scholar
Abstract 230: Proteomic approaches in the discovery of novel drug targets or potential biomarkers in breast cancer
I. Orfanou, T. Karampelas, George Mermelekas, K. Vougas +1 more
20170 citations
Semantic Scholar
A gemcitabine based peptide conjugate with improved metabolic properties, dual mode of action and efficacy in animal models
T. Karampelas, E. Skavatsou, O. Argyros, C. Tamvakopoulos
20160 citations
Semantic Scholar
Erratum to: Pharmacokinetics, Safety, and Efficacy of Chemoembolization with Doxorubicin-Loaded Tightly Calibrated Small Microspheres in Patients with Hepatocellular Carcinoma
K. Malagari, T. Kiakidis, M. Pomoni, H. Moschouris +16 more
2016Cardiovascular and Interventional Radiology0 citations Open access
Semantic Scholar
Abstract 2618: Gemcitabine based peptide conjugates: Overcoming the pitfalls of conventional therapies by targeted approaches
C. Tamvakopoulos, T. Karampelas, O. Argyros
20150 citations
Semantic Scholar
Bioavailability and pharmacokinetic evaluation of GnRH conjugates
T. Karampelas, Θεόδωρος Καράμπελας
20140 citations
Semantic Scholar
755: A gemcitabine prodrug for the treatment of castration-resistant prostate cancer: Reduced metabolic inactivation combined with targeted drug delivery
T. Karampelas, Orestis Argyros, Nisar Sayyad, A. Tzakos +2 more
20140 citations
Semantic Scholar
824 Cancer Cell's Surface Traits – an Ally in Designing Targeted Cancer Therapies – a GnRH Based Approach
T. Karampelas, O. Argyros, N. Kostomitsopoulos, K. Morgan +4 more
20120 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

C. Tamvakopoulos×21
Invite
C. Tamvakopoulos — researcher profile on SciRah
Demosthenes Fokas×9
Invite
Demosthenes Fokas — researcher profile on SciRah
O. Argyros×7
Invite
O. Argyros — researcher profile on SciRah
Nisar Sayyad×6
Invite
Nisar Sayyad — researcher profile on SciRah

×6

Invite

A. Tzakos — researcher profile on SciRah

Achilles Chatziioannou×4

Invite

Achilles Chatziioannou — researcher profile on SciRah

Xenophon Asvos×4

Invite

Xenophon Asvos — researcher profile on SciRah

E. Skavatsou×4

Invite

E. Skavatsou — researcher profile on SciRah

Invite

K. Malagari — researcher profile on SciRah

Invite

M. Pomoni — researcher profile on SciRah

H. Moschouris×3

Invite

H. Moschouris — researcher profile on SciRah

Invite

A. Kelekis — researcher profile on SciRah